The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation

Oncogene. 2007 Mar 8;26(11):1577-85. doi: 10.1038/sj.onc.1209949. Epub 2006 Sep 4.

Abstract

Tel-Abl and Tel-Jak2 are fusion proteins associated with human haematologic neoplasms. They possess constitutive tyrosine kinase activity and activate common downstream signalling pathways like Stat-5, PI3-K/Akt, Ras/MapK and NF-kappaB. In this study, we showed the specific requirement of Src family members for the Tel-Abl-mediated cell growth, activation of Stat5, PI3-K/Akt and Ras/MapK while dispensable for Tel-Jak2. Hck was found strongly phosphorylated in Tel-Abl-expressing Ba/F3 cells and sensitive to imatinib mesylate treatment, providing evidence that Hck is a target of Tel-Abl tyrosine kinase activity. Overexpression of a kinase dead form of Hck inhibits the proliferation of Ba/F3 cells expressing Tel-Abl as the phosphorylation of Akt and Erk1/2. These results argue for an important role of Hck in Tel-Abl oncogenic signalling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzamides
  • Cell Line
  • Cell Transformation, Neoplastic*
  • Humans
  • Imatinib Mesylate
  • Oncogene Proteins, Fusion / physiology*
  • Phosphorylation
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Protein-Tyrosine Kinases / physiology*
  • Proto-Oncogene Proteins c-hck / antagonists & inhibitors
  • Proto-Oncogene Proteins c-hck / metabolism*
  • Pyrimidines / pharmacology

Substances

  • Benzamides
  • Oncogene Proteins, Fusion
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • TEL-ABL fusion protein, human
  • TEL-JAK2 fusion protein, human
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • HCK protein, human
  • Proto-Oncogene Proteins c-hck